Institutional Repository of Vilnius University
Mikrobiotos- žarnyno- smegenų ašies vaidmuo Alzheimerio ligos ir II tipo cukrinio diabeto patogenezėje /
Abstract
dc:descriptionOver the last decades, the view of the gut microbiota and its systemic role in the human organism has evolved considerably. Research on the gut microbiota and its interactions with Alzheimer's disease and type 2 diabetes is becoming crucial to better understand the mechanisms of these diseases and to find ways to prevent and treat them. The aim of this thesis is to evaluate the impact of gut microbiota and dysbiosis on cognitive and physiological functions in mice from patients with Alzheimer's disease and type 2 diabetes. In this study were used 72 C57BL/6J line mice. Five experimental groups were formed. Three groups were divided according to the microbiota of the human donors (Alzheimer's disease, type II diabetes and both Alzheimer's disease and type II diabetes). The fourth group received gut microbiota transplants from people who were healthy, i.e. they did not suffer from any neurodegenerative, metabolic or other disease known to them. The fifth group was injected with saline instead of microbiota. At 10 weeks after the first microbiota transfer procedure (the microbiota transfer was carried out for 17 weeks), cognitive and physiological functions of the mice were assessed. The gut microbiota transfer procedure was found to be effective: the microbiota colonised the gastrointestinal tract and mice receiving microbiota from the same donor showed similar cognitive and physiological function results. Studies on cognitive function have shown that microbiota and dysbiosis in humans with type 2 diabetes adversely affect cognitive function in mice. Dysbiosis adversely affects the ability of mice to feel pleasure (predisposing mice to anhedonia). The microbiota of type 2 diabetics increases the level of anxiety in mice. There is also a tendency that microbiota and dysbiosis in humans with Alzheimer's disease and type 2 diabetes increase anxiety in mice, while microbiota from humans with Alzheimer's disease or type 2 diabetes negatively affect long-term memory in mice. Studies on physiological parameters have shown that the microbiota of people with type 2 diabetes or Alzheimer's disease adversely affects the circadian rhythm, a physiological function of mice, and that the microbiota of patients with both diseases shows tendency to activate the intestinal peristaltic of the mice and to have an adverse effect on the glucose metabolism.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Keršytė, Karolina,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192842685&prefLang=en_US